Rontalizumab (Anti-IFNa1)
Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.
| Trivial name | RhuMab IFNalpha |
| Catalog Number | A2664 |
| CAS# | 948570-30-7 |
| Size | 1mg*25 |